Not Medicare Enrolled

Dr. Tsu-Hui Lin, M.D.

Pediatric Endocrinology · Tampa, FL
Low-engagement
3001 W MARTIN LUTHER KING BOULEVARD, Tampa, FL 33607
8135548420
In practice since 2006 (20 years)
NPI: 1760460992 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lin

Dr. Tsu-Hui Lin is a pediatric endocrinology in Tampa, FL, with 20 years in practice.

Between the years covered by Open Payments, Dr. Lin received a total of $2,495 from 31 pharmaceutical and/or device companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lin is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $2,495 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,495
Total received (2018-2024)
Avg $356/year across 7 years
Top 40% in FL for pediatric endocrinology
31
Companies
106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,495 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$758
2023
$382
2022
$196
2021
$391
2020
$16
2019
$183
2018
$568

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Insulet Corporation
$321
Novo Nordisk Inc
$311
Dexcom, Inc.
$157
ABBVIE INC.
$155
AbbVie, Inc.
$141
Ultragenyx Pharmaceutical Inc.
$120
PFIZER INC.
$114
Abbott Laboratories
$108
TOLMAR Pharmaceuticals, Inc.
$104
Eton Pharmaceuticals, Inc.
$102
Tandem Diabetes Care, Inc.
$94
LifeScan, Inc.
$88
Azurity Pharmaceuticals, Inc.
$84
SANOFI-AVENTIS U.S. LLC
$73
Ascendis Pharma Inc
$70
GENZYME CORPORATION
$50
BioMarin Pharmaceutical Inc.
$48
Xeris Pharmaceuticals, Inc.
$48
BETA BIONICS, INC.
$42
ARBOR PHARMACEUTICALS, INC.
$34
Neurocrine Biosciences, Inc.
$28
AbbVie Inc.
$27
Chiesi USA, Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$21
Rhythm Pharmaceuticals, Inc.
$20
Zealand Pharma US, Inc.
$20
LIFESCAN, INC.
$20
Lilly USA, LLC
$20
Tolmar, Inc.
$19
DEXCOM, INC.
$18
Medtronic, Inc.
$16
Top 3 companies account for 31.6% of total payments
Associated products mentioned in payments ›
ALKINDI · BAQSIMI · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · FENSOLVI · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GENOTROPIN · GVOKE HYPOPEN · GVOKE PFS · INGREZZA · Imcivree · InPen · LUPRON DEPOT · Lupron · Lupron Depot · MYALEPT · Norditropin · ONETOUCH VERIO FLEX · Omnipod · OneTouch · OneTouch Verio Reflect · Palynziq · SKYTROFA · Skytrofa · Sogroya · TRIPTODUR · TZIELD · Tresiba · Triptodur · VOXZOGO 1.2mg · VPRIV · Wegovy · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pediatric endocrinology in Tampa?
Compare pediatric endocrinologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologys nearby

Geographic Context

Pediatric Endocrinologys within 10 mi
17
Per 100K population
1.1
County median income
$75,011
Nearest hospital
ST JOSEPHS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lin is a pediatric endocrinology, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $2,495 from 31 companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →